Research output per year
Research output per year
Personal profile
Expertises
Psoriasis; Atopic dermatitis; Rosacea; Biologics; Registries; Epidemiology; Pharmacoepidemiology
Main research areas
Psoriasis; Atopic dermatitis; Rosacea; Biologics; Registries; Epidemiology; Pharmacoepidemiology
Potential conflicts of interest
Dr. Egeberg has received research funding from Pfizer and Eli Lilly, and honoraria as consultant and/or speaker from Pfizer, Eli Lilly, Novartis, Galderma, and Janssen Pharmaceuticals
Fingerprint
Dive into the research topics where Alexander Egeberg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Adverse Events in Patients Receiving Placebo in Phase III Trials of Biologics for Psoriasis: A Systematic Review and Meta-Analysis
Ajenthen, G. D., Egeberg, A., Melgaard, K. E. & Loft, N., Jan 2023, In: Journal of Psoriasis and Psoriatic Arthritis. 8, 1, p. 19-23 5 p.Research output: Contribution to journal › Review › peer-review
-
A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head-and-neck dermatitis
Vittrup, I., Krogh, N. S., Larsen, H. H. P., Elberling, J., Skov, L., Ibler, K. S., Jemec, G. B. E., Mortz, C. G., Bach, R. O., Bindslev-Jensen, C., Dalager, M. G., Egeberg, A., Agner, T., Deleuran, M., Vestergaard, C. & Thyssen, J. P., 6 Jan 2023, (E-pub ahead of print) In: Journal of the European Academy of Dermatology and Venereology : JEADV.Research output: Contribution to journal › Journal article › Research › peer-review
-
Long-term clearance of severe plaque psoriasis with oral roflumilast
Gyldenløve, M., Meteran, H., Zachariae, C. & Egeberg, A., Mar 2023, In: Journal of the European Academy of Dermatology and Venereology : JEADV. 37, 3, p. e429-e430Research output: Contribution to journal › Letter › peer-review
-
Machine learning model for predicting outcomes of biologic therapy in psoriasis
Du, A. X., Ali, Z., Ajgeiy, K. K., Dalager, M. G., Dam, T. N., Egeberg, A., Nissen, C. V. S., Skov, L., Thomsen, S. F., Emam, S. & Gniadecki, R., 30 Jan 2023, (E-pub ahead of print) In: Journal of the American Academy of Dermatology.Research output: Contribution to journal › Letter › peer-review
-
Pharmacological treatment of cardiovascular risk factors in patients with psoriasis: A Danish nationwide study
Liljendahl, M. S., Loft, N., Passey, A., Wegner, S., Egeberg, A. & Skov, L., 17 Jan 2023, (E-pub ahead of print) In: Journal of the European Academy of Dermatology and Venereology.Research output: Contribution to journal › Letter › peer-review